Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)-Reference-Cited by-同舟云学术

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)

Published:2002-02 Issue:3 Volume:16 Page:369-379
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Cingolani Antonella,Antinori Andrea,Rizzo Maria Gabriella,Murri Rita,Ammassari Adriana,Baldini Francesco,Di Giambenedetto Simona,Cauda Roberto,De Luca Andrea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference31 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

3. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

4. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

5. Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review;Viruses;2023-08-13

2. Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells;Clinical Microbiology Reviews;2022-12-21

3. Towards Next-Generation Sequencing for HIV-1 Drug Resistance Testing in a Clinical Setting;Viruses;2022-10-07

4. First report of computational protein–ligand docking to evaluate susceptibility to HIV integrase inhibitors in HIV-infected Iranian patients;Biochemistry and Biophysics Reports;2022-07

5. Exploiting genomics to mitigate the public health impact of antimicrobial resistance;Genome Medicine;2022-02-16